Expression study of three secretory proteins (Prostatic secretory protein of 94 amino acids, probasin, and seminal vesicle secretion II) in dysplastic and neoplastic rat prostates

Prostate

Volumn 56, Issue 2, 2003, Pages 81-97

  Kwong, Joseph ^a   Lui, K ^a   Chan, Peter S F ^a   Ho, Shuk Mei ^c   Wong, Y C ^b   Xuan, J W ^d   Chan, Franky L ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Androgen independent prostatic tumor; Dunning prostatic adenocarcinoma; Dysplasia; Noble rat prostate; Prostatic intraepithelial neoplasia; Prostatic secretory proteins

Indexed keywords

ANDROGEN; PROBASIN; PROSTATIC SECRETORY PROTEIN; SEMINAL VESICLE SECRETORY PROTEIN; ANDROGEN BINDING PROTEIN; BETA MICROSEMINOPROTEIN; BETA-MICROSEMINOPROTEIN; MESSENGER RNA; SVS2 PROTEIN, RAT; TUMOR MARKER;

ANDROGEN RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRADING; CANCER MODEL; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPATHOLOGY; DISEASE MARKER; EPITHELIUM DYSPLASIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MALIGNANT TRANSFORMATION; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE ADENOMA; PROSTATE HYPERTROPHY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETORY CELL; SEMINAL VESICLE; ADENOCARCINOMA; ANIMAL; CHEMISTRY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; PATHOPHYSIOLOGY; PROSTATE; PROSTATE TUMOR; RAT STRAIN; SECRETION;

ADENOCARCINOMA; ANDROGEN-BINDING PROTEIN; ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; PROSTATIC SECRETORY PROTEINS; RATS; RATS, INBRED STRAINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEMINAL VESICLE SECRETORY PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0042308763     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10228     Document Type: Article

References (92)

1. Leav I, Ho SM, Ofner P, Merk FB, Kwan PWL, Damber JE. Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. J Natl Cancer Inst 1988;80:1045-1053.
2. Leav I, Merk FB, Kwan PW, Ho SM. Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Noble rats. Prostate 1989;15:23-40.
3. Xie W, Wong YC, Tsao SW. Correlation of increased apoptosis and proliferation with development of prostatic intraepithelial neoplasia (PIN) in ventral prostate of the Noble rat. Prostate 2000;44:31-39.
4. Li SC, Chen GF, Chan PSF, Choi HL, Ho SM, Chan FL. Altered expression of extracellular matrix and proteinases in Noble rat prostate gland after long-term treatment with sex steroids. Prostate 2001;49:58-71.
5. Pugh TD, Chang CS, Uemura H, Weindruch R. Prostatic localization of spontaneous early invasive carcinoma in Lobund-Wistar Rats. Cancer Res 1994;54:5766-5770.
6. Banerjee PP, Banerjee S, Lai JM, Strandberg JD, Zirkin BR, Brown TR. Age-dependent and lobe-specific spontaneous hyperplasia in the Brown Norway rat prostate. Biol Reprod 1998;59:1163-1170.
7. Müntzing J, Sufrin G, Murphy GP. Prostatitis in the rat. Scand J Urol Nephrol 1979;13:17-22.
8. Gerhardt PG, Mevåg B, Tveter KJ, Purvis K. A systematic study of biochemical differences between the lobes of the rat prostate. Int J Androl 1983;6:553-562.
9. Dodd JG, Sheppard PC, Matusik RJ. Characterization and cloning of rat dorsal prostate mRNAs. Androgen regulation of two closely related abundant mRNAs. J Biol Chem 1983;258:10731-10737.
10. Matuo Y, Nishi N, Muguruma Y, Yoshitake Y, Kurata N, Wada F. Localization of prostatic basic protein (probasin) in the rat prostates by use of monoclonal antibody. Biochem Biophys Res Commun 1985;130:293-300.
11. Matusik RJ, Kreis C, McNicol P, Sweetland R, Mullin C, Fleming WH, Dodd JG. Regulation of prostatic genes: Role of androgens and zinc in gene expression. Biochem Cell Biol 1986;64:601-607.
12. Dodd JG, Kreis C, Sheppard PC, Hamel A, Matusik RJ. Effect of androgens on mRNA for a secretory protein of rat dorsolateral prostate and seminal vesicles. Mol Cell Endocrinol 1986;47:191-200.
13. Harris SE, Harris MA, Johnson CM, Bean MF, Dodd JG, Matusik RJ, Carr SA, Crabb JW. Structural characterization of the rat seminal vesicle secretion II protein and gene. J Biol Chem 1990;265:9896-9903.
14. Fernlund P, Granberg L, Larsson I. Cloning of β-microseminoprotein of the rat: A rapidly evolving mucosal surface protein. Arch Biochem Biophys 1996;334:73-82.
15. Kwong J, Xuan JW, Choi HL, Chan PSF, Chan FL. PSP94 (or β-microseminoprotein) is a secretory protein specifically expressed and synthesized in the lateral lobe of the rat prostate. Prostate 2000;42:219-229.
16. Sweetland R, Sheppard PC, Dodd JG, Matusik RJ. Post-castration rebound of an androgen regulated prostatic gene. Mol Cell Biochem 1988;84:3-15.
17. Prins GS, Woodham C, Lepinske M, Birch L. Effects of neonatal estrogen exposure on prostatic secretory genes and their correlation with androgen receptor expression in the separate prostate lobes of the adult rat. Endocrinology 1993;132:2387-2398.
18. Lopes ES, Foster BA, Donjacour AA, Cunha GR. Initiation of secretory activity of rat prostatic epithelium in organ culture. Endocrinology 1996;137:4225-4234.
19. Kwong J, Xuan JW, Chan PSF, Ho SM, Chan FL. A comparative study of hormonal regulation of three secretory proteins (prostatic secretory protein-PSP94, probasin, and seminal vesicle secretion II) in rat lateral prostate. Endocrinology 2000;141:4543-4551.
20. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 1995;92:3439-3443.
21. Kasper S, Sheppard PC, Yan Y, Pettigrew N, Borowsky AD, Prins GS, Dodd JG, Duckworth ML, Matusik RJ. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: A model for prostate cancer. Lab Invest 1998;78:319-333.
22. Asamoto M, Hokaiwado N, Cho YM, Takahashi S, Ikeda Y, Imaida K, Shirai T. Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent. Cancer Res 2001;61:4693-4700.
23. Johansson J, Sheth A, Cederlund E, Jörnvall H. Analysis of an inhibin preparation reveals apparent identity between a peptide with inhibin-like activity and a sperm-coating antigen. FEBS Letts 1984;176:21-26.
24. Seidah NG, Arbatti NJ, Rochemont J, Sheth AR, Chrétien M. Complete amino acid sequence of human seminal plasma β-inhibin. FEBS Letts 1984;175:349-355.
25. Akiyama K, Yoshioka Y, Schmid K, Offner GD, Troxler RF, Tsuda R, Hara M. The amino acid sequence of human β-microseminoprotein. Biochim Biophys Acta 1985;829:288-294.
26. Dubé JY, Frenette G, Paquin R, Chapdelaine P, Tremblay J, Tremblay RR, Lazure C, Seidah N, Chrétien M. Isolation from human seminal plasma of an abundant 16-kDa protein originating from the prostate, its identification with a 94-residue peptide originally described as β-inhibin. J Androl 1987;8:182-189.
27. Mbikay M, Nolet S, Fournier S, Benjannet S, Chapdelaine P, Paradis G, Dubé JY, Tremblay R, Lazure C, Seidah NG, Chrétien M. Molecular cloning and sequence of the cDNA for a 94-amino-acid seminal plasma protein secreted by the human prostate. DNA 1987;6:23-29.
28. Lilja H, Abrahamsson P-A. Three predominant proteins secreted by the human prostate gland. Prostate 1988;12:29-38.
29. Hara M, Kimura H. Two prostate-specific antigens, γ-seminoprotein and β-microseminoprotein. J Lab Clin Med 1989;113:541-548.
30. Abrahamsson P-A, Lilja H, Falkmer S, Wadström LB. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands. Prostate 1988;12:39-46.
31. Hyakutake H, Sakai H, Yogi Y, Tsuda R, Minami Y, Yushita Y, Kanetake H, Nakazono I, Saito Y. Beta-microseminoprotein immunoreactivity as a new prognostic indicator of prostatic carcinoma. Prostate 1993;22:347-355.
32. Yogi Y. A monoclonal antibody assessment of the beta-microseminoprotein expression in prostatic carcinoma as a prognostic indicator. Acta Med Nagasaki 1995;40:13-17.
33. Wu D, Guo Y, Chambers AF, Izawa JI, Chin JL, Xuan JW. Serum bound forms of PSP94 (prostate secretory protein of 94 amino acids) in prostate cancer patients. J Cell Biochem 1999;76:71-83.
34. Lau HL, Zhu XM, Leung PCK, Chan LW, Chen GF, Chan PSF, Yu KL, Chan FL. Detection of mRNA expression of gonadotropin-releasing hormone and its receptor in normal and neoplastic rat prostates. Int J Oncol 2001;19:1193-1201.
35. Ho SM, Leav I, Damassa D, Kwan PWL, Merk FB, Seto HSK. Testosterone-mediated increase in 5α-dihydrotestosterone content, nuclear androgen levels, and cell division in an androgen-independent prostate carcinoma of Noble rats. Cancer Res 1988;48:609-614.
36. Chan FL, Choi HL, Ho SM. Analysis of glycoconjugate patterns of normal and hormone-induced dysplastic Noble rat prostates, and an androgen-independent Noble rat prostate tumor, by lectin histochemistry and protein blotting. Prostate 2001;46:21-32.
37. Noble RL. Development of androgen-stimulated transplants of Nb rat carcinoma of the dorsal prostate and their response to sex hormones and tamoxifen. Cancer Res 1980;40:3551-3554.
38. Noble RL. Prostate carcinoma of the Nb rat in relation to hormones. Int Rev Exp Pathol 1982;23:113-159.
39. Kwong J, Chan FL, Jiang S, Guo Y, Imasato Y, Sakai H, Koropatnick J, Chin JL, Xuan JW. Differential expression of PSP94 in rat prostate lobes as demonstrated by an antibody against recombinant GST-PSP94. J Cell Biochem 1999;74:406-417.
40. Chan FL, Choi HL. Proteoglycans associated with the ciliary zonule of the rat eye: A histochemical and immunohistochemical study. Histochem Cell Biol 1995;104:369-381.
41. McNeal JE, Bostwick DG. Intraductal dysplasia: A premalignant lesion of the prostate. Hum Pathol 1986;17:64-71.
42. Bostwick DG, Brawer MK. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 1987;59:788-794.
43. Bostwick DG, Amin MB, Dundore P, Marsh W, Schultz DS. Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum Pathol 1993;24:298-310.
44. Aumüller G, Hartley-Asp B, Seitz J. Differential reaction of secretory and non-secretory proteins in hormone-treated Dunning tumor. Prostate 1989;15:81-94.
45. McNeal JE, Alroy J, Leav I, Redwine EA, Freiha FS, Stamey TA. Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis. Am J Clin Pathol 1988;90:23-32.
46. Chan PSF, Chan LW, Xuan JW, Chin JL, Choi HL, Chan FL. In situ hybridization of PSP94 (prostatic secretory protein of 94 amino acids) expression in human prostates. Prostate 1999;41:99-109.
47. Dubé JY, Pelletier G, Gagnon P, Tremblay RR. Immunohistochemical localization of a prostatic secretory protein of 94 amino acids in normal prostatic tissue, in primary prostatic tumors, and in their metastases. J Urol 1987;138:883-887.
48. Tsurusaki T, Koji T, Sakai H, Kanetake H, Nakane PK, Saito Y. Cellular expression of beta-microseminoprotein (β-MSP) mRNA and its protein in untreated prostate cancer. Prostate 1998;35:109-116.
49. Schrodt GR. The fine structure of the lateral lobe of the rat prostate gland. Comparison with the dorsal and other lobes. J Ultrastruct Res 1961;5:485-496.
50. Rowlatt C, Franks LM. Myoepithelium in mouse prostate. Nature 1964;202:707-708.
51. Brandes D. The fine structure and histochemistry of prostatic glands in relation to sex hormones. Int Rev Cytol 1966;20:207-276.
52. Dahl E, Kjaerheim Å, Tveter KJ. The ultrastructure of the accessory sex glands of the male rat. I. Normal structure. Z Zellforsch 1973;137:345-359.
53. McNeal JE. Normal histology of the prostate. Am J Surg Pathol 1988;12:619-633.
54. Chan FL, Ho SM. Comparative study of glycoconjugates of the rat prostatic lobes by lectin histochemistry. Prostate 1999;38:1-16.
55. Hayward SW, Brody JR, Cunha GR. An edgewise look at basal epithelial cells: Three-dimensional views of the rat prostate, mammary gland, and salivary gland. Differentiation 1996;60:219-227.
56. Dermer GB. Basal cell proliferation in benign prostatic hyperplasia. Cancer 1978;41:1857-1862.
57. Bostwick DG. Prostatic intraepithelial neoplasia (PIN). Urology 1989;34(Suppl 6):16-22.
58. Brandes D, Kirchheim D, Scott WW. Ultrastructure of the human prostate: Normal and neoplastic. Lab Invest 1964;13:1541-1560.
59. Mao P, Angrist A. The fine structure of the basal cell of human prostate. Lab Invest 1966;15:1768-1782.
60. Ichihara I, Pelliniemi LJ. Ultrastructure of the basal cell and the acinar capsule of rat ventral prostate. Anat Anz 1975;138:355-364.
61. English HF, Santen RJ, Isaacs JT. Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 1987;11:229-242.
62. Bonkhoff H, Stein U, Remberger K. The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 1994;24:114-118.
63. Bonhkoff H. Role of the basal cells in premalignant changes of the human prostate: A stem cell concept for the development of prostate cancer. Eur Urol 1996;30:201-205.
64. Bonhkoff H, Remberger K. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model. Prostate 1996;28:98-106.
65. De Marzo AM, Nelson WG, Meeker AK, Coffey DS. Stem cell features of benign and malignant prostate epithelial cells. J Urol 1998;160:2381-2392.
66. Sanefuji H, Heatfield BM, Trump BF, Young JD Jr. Studies on carcinogenesis of human prostate. II. Long-term explant culture of normal prostate and benign prostatic hyperplasia: Light microscopy. J Natl Cancer Inst 1982;69:751-756.
67. Heatfield BM, Sanefuji H, Trump BF. Studies on carcinogenesis of human prostate. III. Long-term explant culture of normal prostate and benign prostatic hyperplasia: Transmission and scanning electron microscopy. J Natl Cancer Inst 1982;69:757-766.
68. Montironi R, Bostwick DG, Bonkhoff H, Cockett ATK, Helpap B, Troncoso P, Waters D. Workgroup 1. Origins of prostate cancer. Cancer 1996;78:362-365.
69. McNeal JE, Kaillot O, Yemoto C. Cell proliferation in dysplasia of the prostate: Analysis by PCNA immunostaining. Prostate 1995;27:258-268.
70. Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson M, Olsson CA, Korsmeyer S, Buttyan R. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am J Pathol 1993;143:390-400.
71. Verhagen APM, Aalders TW, Ramaekers FCS, Debruyne FMJ, Schalken JA. Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration. Prostate 1988;13:25-38.
72. Verhagen APM, Ramaekers FCS, Aalders TW, Ewout Schaafsma H, Debruyne FMJ, Schalken JA. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res 1992;52:6182-6187.
73. Prins GS, Birch L, Greene GL. Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology 1991;129:3187-3199.
74. Ruizeveld de Winter JA, Trapman J, Vermey M, Mulder E, Zegers ND, van der Kwast TH. Androgen receptor expression in human tissues: An immunohistochemical study. J Histochem Cytochem 1991;39:927-936.
75. Iwamura M, Abrahamsson P-A, Benning CM, Cockett ATK, di Sant'Agnese PA. Androgen receptor immunostaining and its tissue distribution in formalin-fixed, paraffin-embedded sections after microwave treatment. J Histochem Cytochem 1994;42:783-788.
76. Janssen PJ, Brinkmann AO, Boersma WJ, van der Kwast TH. Immunohistochemical detection of the androgen receptor with monoclonal antibody F39.4 in routinely processed, paraffin-embedded human tissues after microwave pre-treatment. J Histochem Cytochem 1994;42:1169-1175.
77. Bonhkoff H, Remberger K. Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Arch A Pathol Anat Histopathol 1993;422:35-38.
78. Kimura N, Mizokami A, Oonuma T, Sasano H, Nagura H. Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. J Histochem Cytochem 1993;41:671-678.
79. Soeffing WJ, Timms BG. Localization of androgen receptor and cell-specific cytokeratins in basal cells of rat ventral prostate. J Androl 1995;16:197-208.
80. Mirosevich J, Bentel JM, Zeps N, Redmond SL, D'Antuono MF, Dawkins HJS. Androgen receptor expression of proliferating basal and luminal cells in adult murine ventral prostate. J Endocrinol 1999;162:341-350.
81. Leav I, McNeal JE, Kwan PWL, Komminoth P, Merk FB. Androgen receptor expression in prostatic dysplasia (prostatic intraepithelial neoplasia) in the human prostate: An immunohistochemical and in situ hybridization study. Prostate 1996;29:137-145.
82. Van der Kwast TH, Têtu B. Androgen receptors in untreated and treated prostatic intraepithelial neoplasia. Eur Urol 1996;30:265-268.
83. Harper ME, Glynne-Jones E, Goddard L, Mathews P, Nicholson RI. Expression of androgen receptor and growth factors in premalignant lesions of the prostate. J Pathol 1998;186:169-177.
84. Yu M, Leav BA, Leav I, Merk FB, Wolfe HJ, Ho SM. Early alterations in ras protooncogene mRNA expression in testosterone and estradiol-17β induced prostatic dysplasia of Noble rats. Lab Invest 1993;68:33-44.
85. Bonkhoff H, Fixemer T, Remberger K. Relation between Bcl-2, cell proliferation, and the androgen receptor status in prostate tissue and precursors of prostate cancer. Prostate 1998;34:252-258.
86. Isaacs JT. Development and characteristics of the available animal model systems for the study of prostatic cancer. In: Coffey DS, Bruchovsky N, Gardner WA, Resnick MI, Karr JP, editors. Current concepts and approaches to the study of prostate cancer. Prog clin biol res. Vol. 239. New York: Alan R. Liss, Inc.; 1987. pp 513-576.
87. Dunning WF. Prostate cancer in the rat. In: Vollmer EP, editor. Biology of the prostate and related tissues. Natl cancer inst monogr. Vol. 12. Bethesda: National Cancer Institute; 1963. pp 351-369.
88. Goebel HW, Rausch U, Steinhoff M, Seitz J, Bacher M, Papotti M, Bussolati G, Tuohimma P, Aumüller G. Arguments against the prostatic origin of the R-3327 Dunning H tumor. Virchows Arch B 1992;62:9-18.
89. Pollard M. Commentary on the Dunning tumor. Prostate 1995;26:287-289.
90. Aumüller G, Gröschel-Stewart U, Altmannsberger M, Mannherz HG, Steinhoff M. Basal cells of H-Dunning tumor are myoepithelial cells. A comparative immunohistochemical and ultrastructural study with male accessory sex glands and mammary gland. Histochemistry 1991;95:341-349.
91. Gabril MY, Onita T, Ji PG, Sakai H, Chan FL, Koropatnick J, Chin JL, Moussa M, Xuan JW. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model. Gene Ther 2002;9:1589-1599.
92. Spence AM, Sheppard PC, Davie JR, Matuo Y, Nishi N, McKeehan WL, Dodd JG, Matusik RJ. Regulation of a bifunctional mRNA results in synthesis of secreted and nuclear probasin. Proc Natl Acad Sci USA 1989;86:7843-7847.